Remove Corporate Finance Remove Medical Remove Private Equity
article thumbnail

FOCUS Investment Banking Represents Dulles Eye Associates in its Partnership with ReFocus Eye Health

Focus Investment Banking

Washington, DC, (September 27, 2024) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture, and corporate finance services, announced today that Dulles Eye Associates has joined ReFocus Eye Health as a supported practice.

article thumbnail

FOCUS Investment Banking Represents Mid-Michigan ENT in its Partnership with Align ENT + Allergy

Focus Investment Banking

They are among the most active advisors to medical professionals in transactions with private equity-backed organizations. FOCUS managing directors Eric Yetter and Andy Snyder advised Mid-Michigan ENT in this partnership.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FOCUS Investment Banking Represents CORE Industrial Partners in its Acquisition of MSK Precision Products, Inc.

Focus Investment Banking

Targeting sectors with rigorous technical specifications, regulatory compliance standards, and exacting quality requirements, MSK serves customers primarily in the medical, aerospace & defense and telecommunications end markets.

article thumbnail

FOCUS Investment Banking Represents CORE Industrial Partners in its Acquisition of National Manufacturing Co, Inc.

Focus Investment Banking

Serving a variety of end markets, including aerospace & defense, electronics and industrials, National offers especially deep experience in the medical end market across various implantable devices, including pacemakers, neuromodulation devices, defibrillators, batteries and capacitors. National”).

article thumbnail

Shareholders vs. Stakeholders - Understanding Corporate Responsibilities

Peak Frameworks

For example, while a pharmaceutical company focused solely on shareholder value might prioritize high-margin drugs for rare conditions, a stakeholder-oriented approach might consider affordability and broader societal health needs , as seen with Gilead's approach to its HIV medications.

article thumbnail

FOCUS Investment Banking Represents Michigan ENT & Allergy Specialists in its sale to Parallel ENT & Allergy

Focus Investment Banking

They are among the most active advisors to medical professionals in transactions with private equity-backed organizations. They are among the most active advisors to medical professionals in transactions with private equity-backed organizations. “We who serves as Michigan ENT’s managing partner.

article thumbnail

FOCUS Investment Banking Represents CORE Industrial Partners in its Acquisition of Coining Manufacturing and Precision Machine Products

Focus Investment Banking

CORE, a private equity firm focused on manufacturing, industrial technology, and industrial services, previously acquired GEM, a provider of precision deep-drawn metal components and mechanical assemblies, in February 2023. PMP”), a provider of specialty stamping and machining services. FOCUS represented CORE in this transaction.